Low procalcitonin, community acquired pneumonia, and antibiotic therapy

Lancet Infect Dis. 2018 May;18(5):496-497. doi: 10.1016/S1473-3099(18)30215-9.

Authors

Ishan S Kamat¹, Vignesh Ramachandran², Harish Eswaran², Michael S Abers³, Daniel M Musher²

Affiliations

¹ Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: Ishan.kamat@bcm.edu.
² Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
³ Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.

PMID: 29695359
DOI: 10.1016/S1473-3099(18)30215-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Community-Acquired Infections*
Humans
Pneumonia*
Procalcitonin
Respiratory Tract Infections

Substances

Anti-Bacterial Agents
Procalcitonin